Aster DM Merger Nears Finish Line with 97% Shareholder Nod

Introduction

Aster DM Healthcare Limited has moved a significant step closer to finalizing its merger with Quality Care India Limited, after securing overwhelming approval from its shareholders and creditors. In meetings convened on March 10, 2026, as directed by the National Company Law Tribunal (NCLT), the proposed Scheme of Amalgamation received strong backing, signaling robust stakeholder confidence in the creation of a leading national healthcare provider.

Overwhelming Stakeholder Endorsement

The results from the NCLT-mandated meetings underscore the broad support for the merger. Equity shareholders voted decisively in favor of the resolution, with an approval rate of 96.68%. The support from unsecured trade creditors was even more emphatic, with the resolution passing with 100% unanimous approval from those who participated in the voting process. This level of consensus is a critical milestone, satisfying the regulatory requirement for approval from a majority representing three-fourths in value of the creditors.

Details of the Voting Process

The meetings were conducted via video conferencing, adhering to the framework set by the NCLT's Hyderabad Bench. The voting process was designed to be comprehensive, incorporating both remote e-voting, which was open from March 6 to March 9, 2026, and electronic voting during the meeting itself. Out of 1,116 unsecured trade creditors, 51 attended the meeting, with all votes cast in favor of the amalgamation. The process was overseen by Mr. Mohit Kumar Goyal, a Practicing Company Secretary, who acted as the scrutinizer to ensure transparency and accuracy. The official results have been filed with the stock exchanges and are available on the company's website.

Strategic Vision Behind the Merger

Dr. Azad Moopen, Founder Chairman of Aster DM Healthcare, highlighted the strategic importance of the merger, noting that the strong shareholder support reflects confidence in the long-term value creation potential of the combined entity. The amalgamation is designed to merge Aster's established patient-centric care model with the institutional strength and growth expertise of Quality Care India. The transaction aims to build a resilient and diversified healthcare platform with a significant presence across key Indian markets.

A New Healthcare Giant Emerges

The successful combination of Aster DM Healthcare and Quality Care India will create one of the top three hospital chains in the country. The merged entity will have a formidable presence, boasting a network of 39 hospitals with a combined capacity of over 10,625 beds. This expansive network will span nine states and 28 cities, supported by a dedicated workforce of more than 36,307 employees and clinicians. This scale is expected to enhance operational efficiencies and broaden patient access to quality healthcare services.

Financial Synergies and Growth Potential

The merger is projected to unlock significant financial and operational benefits. Management has identified potential for an EBITDA upside of 10-15%, driven by synergies in procurement, supply chain management, and the integration of clinical models. The combined platform is also expected to have stronger financial metrics, providing a solid foundation for both brownfield and greenfield expansion projects. The minimal overlap in micro-markets between the two entities reduces the risk of operational cannibalization and maximizes growth opportunities.

Regulatory Pathway and Final Steps

This stakeholder approval follows earlier clearances from other key regulatory bodies. The merger has already received a no-objection from the stock exchanges (BSE and NSE) and approval from the Competition Commission of India (CCI). With shareholder and creditor consent now secured, the final major step is to obtain the formal sanction for the Scheme of Amalgamation from the National Company Law Tribunal. The company anticipates that the merger will be completed in the next quarter, pending this final regulatory approval.

Conclusion

The overwhelming approval from both shareholders and creditors marks a pivotal moment for Aster DM Healthcare and Quality Care India. It validates the strategic rationale behind the merger and sets a clear path for the formation of a dominant player in the Indian healthcare sector. As the companies await the final NCLT sanction, the focus will shift to integrating operations and realizing the synergies expected to drive long-term growth and shareholder value.